Us2.ai uses machine learning to automate the fight against heart disease. The company’s software tools improve clinical decision-making and cardiovascular research for clinical trials using echocardiography, the safest and most common cardiac imaging modality. Us2.ai connects institutions and imaging labs worldwide with ready-to-use automation tools for view classification, segmentation and federated learning across diverse, anonymous patient and disease cohorts. Us2.ai is a fast-growing startup backed by IHH Healthcare, Heal Partners, Sequoia India and EDBI.

Project: Developing AI-powered platform to democratise echocardiography

We are building a global data network housed in some of the world's preeminent imaging labs and academic institutions. This data is the foundation for machine learning and statistical analysis for disease prediction studies. We are collaborating with some of the world's top cardiovascular researchers to structure, analyse and publish this data, while incorporating the algorithms into a SaaS based product for clinical use.